Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2023-12-07 | 2024-01-11 | 212717 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2024-01-18 | 2024-06-29 | 216463 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2024-05-16 | 2024-08-27 | 228146 |
| TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2017-04-25 | 2018-01-03 | 8055 |
| TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2017-08-01 | 2017-10-17 | 17832 |
| REMIFENTANIL FOR INJECTION | 1MG | POWDER FOR SOLUTION | Actual shortage | 2020-01-24 | 2020-01-24 | 104313 |
| REMIFENTANIL FOR INJECTION | 2MG | POWDER FOR SOLUTION | Actual shortage | 2020-01-24 | 2020-01-24 | 104316 |
| REVIA | 50MG | TABLET | Resolved | 2023-04-27 | 2023-06-09 | 190707 |
| REVIA | 50MG | TABLET | Resolved | 2024-01-11 | 2024-02-13 | 215710 |
| REVIA | 50MG | TABLET | Resolved | 2025-05-15 | 2025-07-03 | 257513 |
| SEASONALE | 0.03MG 0.15MG | TABLET | Resolved | 2019-09-27 | 2019-09-27 | 94940 |
| SEASONALE | 0.15MG 0.03MG | TABLET | Resolved | 2020-10-08 | 2021-02-25 | 126038 |
| SEASONALE | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176815 |
| SEASONALE | 0.03MG 0.15MG | TABLET | Resolved | 2024-07-04 | 2024-07-11 | 232223 |
| SEASONALE | 0.03MG 0.15MG | TABLET | Resolved | 2025-05-22 | 2025-05-30 | 258124 |
| SEASONALE | 0.03MG 0.15MG | TABLET | Resolved | 2025-06-03 | 2025-10-02 | 259159 |
| SEASONIQUE | 0.01MG 0.03MG 0.15MG | TABLET | Resolved | 2019-09-26 | 2021-03-25 | 94905 |
| SEASONIQUE | 0.01MG 0.15MG 0.03MG | TABLET | Resolved | 2020-10-08 | 2021-02-25 | 126035 |
| SEASONIQUE | 0.15MG 0.01MG 0.03MG | TABLET | Resolved | 2025-06-03 | 2025-10-02 | 259166 |
| SEASONIQUE | 0.15MG 0.01MG 0.03MG | TABLET | Actual shortage | 2025-10-16 | 2025-11-27 | 269687 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LAMOTRIGINE | 25MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81388 |
| TEVA-LAMOTRIGINE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258646 |
| TEVA-LAMOTRIGINE | 150MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258652 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-04-25 | 2025-04-25 | 255824 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-04-29 | 2025-04-29 | 256085 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258507 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258510 |
| TEVA-LATANOPROST | 50MCG | SOLUTION | Discontinued | 2020-07-10 | 2020-07-10 | 120009 |
| TEVA-LEVOCARBIDOPA | 25MG 250MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258625 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81298 |
| TEVA-LISINOPRIL (TYPE P) | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81400 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104257 |
| TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Discontinued | 2019-08-15 | 2019-08-15 | 91648 |
| TEVA-LISINOPRIL (TYPE Z) | 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258694 |
| TEVA-LISINOPRIL (TYPE Z) | 5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258699 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81301 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 25MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81368 |